↓ Skip to main content

Galectin‐3: an early predictive biomarker of modulation of airway remodeling in patients with severe asthma treated with omalizumab for 36 months

Overview of attention for article published in Clinical and Translational Allergy, March 2017
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
1 X user
facebook
1 Facebook page
f1000
1 research highlight platform

Citations

dimensions_citation
58 Dimensions

Readers on

mendeley
52 Mendeley